S 1681
116th Congress
Senate
Health
Drug safety, medical device, and laboratory regulation
Government information and archives
Health personnel
Immunology and vaccination
Licensing and registrations
Manufacturing
Medical education
Medicare
Prescription drugs
Advancing Education on Biosimilars Act of 2020
Introduced: May 23, 2019
See on congress.gov
Everywhere this bill has been
9 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Dec 18, 2020
Held at the desk.
Dec 18, 2020
Received in the House.
Dec 18, 2020
Message on Senate action sent to the House.
Dec 17, 2020
Passed Senate with an amendment by Unanimous Consent. (text of amendment in the nature of a substitute: CR S7643)
Dec 17, 2020
Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
Dec 17, 2020
Measure laid before Senate by unanimous consent. (consideration: CR S7642-7643)
Dec 17, 2020
Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
May 23, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
May 23, 2019
Introduced in Senate
Plain-English summary
Advancing Education on Biosimilars Act of 2019
This bill addresses education for the public and for health care providers regarding biosimilars. (Biosimilars are biological products approved by the Food and Drug Administration based on their similarity to an already approved biological product.)
The bill requires the Department of Health and Human Services (HHS) to create a website for educational materials on the meaning and use of biosimilars and interchangeable biological products.
HHS must also develop or improve continuing medical education programs for health care providers regarding biosimilars.
What's happening now
Held at the desk.
Committees of jurisdiction
1
Cosponsors
1